Palmidrol
- Generic Name
- Palmidrol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H37NO2
- CAS Number
- 544-31-0
- Unique Ingredient Identifier
- 6R8T1UDM3V
- Background
A cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection. Palmidrol is available for human use as a supplement (400 mg capsules) and as food for medical purposes In Italy and Spain (300 mg and 600 mg tablets).
- Associated Conditions
- -
- Associated Therapies
- -
PEA vs. Placebo for Major Depression
- Conditions
- Interventions
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- The Israeli Medical Center for Alzheimer's
- Target Recruit Count
- 100
- Registration Number
- NCT06063369
- Locations
- 🇲🇩
State University of Medicine and Pharmacy " Nicolae Testemitsanu", Chișinău, Moldova, Republic of
Endocannabinoids, Stress, Craving And Pain Effects Study
- Conditions
- Interventions
- First Posted Date
- 2022-07-29
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT05480072
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation
- Conditions
- Interventions
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- University of California, Irvine
- Registration Number
- NCT05317676
- Locations
- 🇺🇸
UC Irvine Medical Center, Orange, California, United States
PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Academic and Community Cancer Research United
- Target Recruit Count
- 88
- Registration Number
- NCT05246670
- Locations
- 🇺🇸
Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, United States
🇺🇸Siouxland Regional Cancer Center, Sioux City, Iowa, United States
🇺🇸Cone Health Cancer Center, Greensboro, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.